EUROLAB
usp-730-plasma-spectrochemistry-for-impurity-profiling
Impurity Profiling EMA Guideline on Genotoxic Impurities in PharmaceuticalsEMA Reflection Paper on Low Level ImpuritiesFDA Guidance: Microbial Impurities and Endotoxin LevelsFDA Guidance: Threshold of Toxicological Concern (TTC) for ImpuritiesFDA ICH M3(R2): Impurities in Safety StudiesFDA Q&A on Impurities in Generic Drug ApplicationsFDA Q&A: Managing Impurities in Complex APIsICH E14: QT Interval Evaluation and Impurity ImpactICH M7: Mutagenic Impurity Risk AssessmentICH Q10: Pharmaceutical Quality System for Impurity ManagementICH Q11: Impurity Control Strategy in Drug Substance DevelopmentICH Q12: Lifecycle Management of Impurity Control StrategyICH Q1E: Evaluation of Stability Data Related to Impurity FormationICH Q2(R1): Validation of Analytical Methods for Impurity TestingICH Q3A: Organic Impurity Profiling in Drug SubstancesICH Q3B: Impurity Testing in Finished Drug ProductsICH Q3C: Residual Solvent ProfilingICH Q3D: Elemental Impurity Risk AssessmentICH Q3F: Impurity Guidelines for Biotechnology ProductsICH Q4B: Harmonization of Analytical Procedures for Impurity TestingICH Q5C: Impurity Monitoring in Biotechnological ProductsICH Q6A: Specifications and Acceptance Criteria for ImpuritiesICH S3A: Impurities Arising from Degradation ProductsICH S6: Biotech Product Impurity ProfilingICH S7A: Safety Pharmacology Impurity EvaluationICH S9: Impurities in Oncology ProductsISO 10993-18: Chemical Characterization and Impurity AnalysisISO 17025: Accreditation for Impurity Testing LaboratoriesJP General Rule 2.60: Limit Test for ImpuritiesPh. Eur. 2.2.28: Gas Chromatography for Impurity DetectionPh. Eur. 2.2.38: Thin-Layer Chromatography for ImpuritiesPh. Eur. 2.2.46: Chromatographic Separation for Impurity AnalysisPh. Eur. 2.4.14: Determination of Inorganic ImpuritiesPh. Eur. 2.4.20: Limit Test for Heavy Metals in ImpuritiesPh. Eur. 2.4.24: Related Substances by HPLC in APIsPh. Eur. 2.4.29: Limit Test for Sulfated Ash ImpuritiesPh. Eur. 2.5.13: Oxidizing Impurity TestsPh. Eur. 2.9.40: Uniformity of Dosage Units and Related ImpuritiesPh. Eur. 5.10: Control of Impurities in Substances for Pharmaceutical UsePh. Eur. 5.4: Impurities in Radiopharmaceutical PreparationsUSP <1010>: Analytical Data Integrity in Impurity ReportingUSP <1031>: The Biocompatibility of Materials and ImpuritiesUSP <1051>: Cleaning Validation Limits and Residual ImpuritiesUSP <1058>: Analytical Instrument Qualification for Impurity StudiesUSP <1078>: Good Manufacturing Practices for Impurity ReductionUSP <1085>: Evaluation of Impurity Method PerformanceUSP <1086>: Impurities in Drug SubstancesUSP <1088>: Forced Degradation Studies for Impurity CharacterizationUSP <1091>: Impurity Isolation and Characterization TechniquesUSP <1099>: Acceptable Analytical Performance CriteriaUSP <1121>: Bulk Pharmaceutical Chemicals and Impurity HandlingUSP <1151>: Pharmaceutical Dosage Forms and Impurity ConsiderationUSP <1191>: Stability Testing of Compounded PreparationsUSP <1222>: Terminal Sterilization Impact on ImpuritiesUSP <1224>: Transfer of Impurity Test ProceduresUSP <1225>: Validation of Compendial Procedures for ImpuritiesUSP <1226>: Verification of Compendial Procedures for Impurity DetectionUSP <1231>: Water for Pharmaceutical Purposes and Impurity EffectsUSP <1232>: Water Activity and Impurity StabilityUSP <1241>: Capsules and Shell Impurity InteractionUSP <1251>: Weighing on Analytical Balances for Micro-ImpuritiesUSP <161>: Transdermal Delivery Systems and Impurity ControlUSP <197>: Spectrophotometric Identification of ImpuritiesUSP <233>: Elemental Impurities Profiling Using ICP-MSUSP <41>: Balances Used for Impurity Weight DeterminationUSP <466>: Identification and Quantification of DegradantsUSP <467>: Residual Solvent Testing in APIs and ExcipientsUSP <476>: Impurity Profiling for New Drug ApplicationsUSP <621>: Chromatography Conditions for Impurity IdentificationUSP <791>: pH Determination Impact on Impurity SolubilityUSP <797>: Sterile Compounding and Impurity ControlUSP <800>: Hazardous Drug Handling Based on Impurity RiskUSP <851>: Spectrophotometry and Light Scattering for ImpuritiesUSP <853>: Atomic Absorption Spectroscopy for Trace ImpuritiesUSP <857>: UV-Vis Spectroscopy for Impurity QuantificationUSP <85>: Bacterial Endotoxin Limits Related to Impurity SafetyUSP <891>: Nuclear Magnetic Resonance (NMR) for Structural ElucidationUSP <905>: Content Uniformity Related to ImpuritiesUSP <905>: Uniformity of Dosage Units Affected by ImpuritiesUSP <941>: Characterization of Impurity Solubility and pKaWHO TRS 970 Annex 2: Impurity Control in Medicines

USP <730>: Plasma Spectrochemistry for Impurity Profiling Laboratory Testing Service Provided by Eurolab

Table of Contents

1. Standard-Related Information(standard-related-information)

1.1 Relevant Standards

1.2 Legal and Regulatory Framework

1.3 Standard Development Organizations

1.4 International and National Standards

1.5 Standard Compliance Requirements for Different Industries

2. Standard Requirements and Needs(standard-requirements-and-needs)

2.1 Business and Technical Reasons for Conducting USP <730> Testing

2.2 Consequences of Not Performing This Test

2.3 Industries and Sectors that Require This Testing

2.4 Quality Assurance and Control Aspects

2.5 Risk Factors and Safety Implications

3. Test Conditions and Methodology(test-conditions-and-methodology)

3.1 Testing Equipment and Instruments Used

3.2 Testing Environment Requirements

3.3 Sample Preparation Procedures

3.4 Testing Parameters and Conditions

3.5 Measurement and Analysis Methods

3.6 Calibration and Validation Procedures

3.7 Quality Control Measures during Testing

4. Test Reporting and Documentation(test-reporting-and-documentation)

4.1 Documenting and Reporting Test Results

4.2 Report Format and Structure

4.3 Interpretation of Test Results

4.4 Certification and Accreditation Aspects

5. Why This Test Should Be Performed(why-this-test-should-be-performed)

5.1 Benefits and Advantages

5.2 Risk Assessment and Mitigation through Testing

5.3 Quality Assurance and Compliance Benefits

5.4 Competitive Advantages and Market Positioning

6. Why Eurolab Should Provide This Service(why-eurolab-should-provide-this-service)

6.1 Expertise and Experience in this Field

6.2 State-of-the-Art Equipment and Facilities

6.3 Qualified and Certified Personnel

6.4 Accreditation and Certification Details

Standard-Related Information

USP <730> is a laboratory testing service that involves the use of plasma spectrochemistry to detect impurities in pharmaceuticals, food products, and other materials. This test is governed by various international and national standards, including ISO, ASTM, EN, TSE, and others.

1.1 Relevant Standards

  • USP <730>: Plasma Spectrochemistry for Impurity Profiling
  • ISO 9001:2015: Quality Management Systems - Requirements
  • ASTM E1619-17: Standard Test Method for Determination of Total Carbon, Hydrogen, and Nitrogen in Acids by Combustion-Gas Chromatography
  • EN ISO/IEC 17025:2017: General Requirements for the Competence of Testing and Calibration Laboratories
  • 1.2 Legal and Regulatory Framework

    The testing service is regulated by various laws and regulations, including:

  • US FDA Good Manufacturing Practice (GMP) Regulations (21 CFR Part 211)
  • EU GMP Guidelines
  • Japanese Ministry of Health, Labour and Welfare (MHLW) Guidelines
  • 1.3 Standard Development Organizations

    The development and revision of standards related to USP <730> testing are undertaken by organizations such as:

  • United States Pharmacopeia (USP): Developing and publishing pharmaceutical compendial standards
  • International Organization for Standardization (ISO): Developing and publishing international standards
  • American Society for Testing and Materials (ASTM): Developing and publishing technical standards
  • 1.4 International and National Standards

    The testing service is governed by various international and national standards, including:

  • USP <730>: Plasma Spectrochemistry for Impurity Profiling
  • ISO 9001:2015: Quality Management Systems - Requirements (for laboratories)
  • EN ISO/IEC 17025:2017: General Requirements for the Competence of Testing and Calibration Laboratories
  • 1.5 Standard Compliance Requirements for Different Industries

    Compliance with USP <730> testing is required by various industries, including:

  • Pharmaceutical industry
  • Food and beverage industry
  • Cosmetics industry
  • Chemicals industry
  • Standard Requirements and Needs

    The need for USP <730> testing arises from the increasing demand for high-quality products that meet regulatory requirements. The consequences of not performing this test can include product recalls, legal liabilities, and damage to reputation.

    2.1 Business and Technical Reasons for Conducting USP <730> Testing

  • Ensuring product safety and efficacy
  • Meeting regulatory requirements
  • Protecting brand reputation
  • Identifying impurities and adulterants
  • 2.2 Consequences of Not Performing This Test

  • Product recalls
  • Legal liabilities
  • Damage to reputation
  • Financial losses
  • 2.3 Industries and Sectors that Require This Testing

  • Pharmaceutical industry
  • Food and beverage industry
  • Cosmetics industry
  • Chemicals industry
  • 2.4 Quality Assurance and Control Aspects

    Quality assurance and control measures are essential for ensuring the accuracy and reliability of test results.

    2.5 Risk Factors and Safety Implications

    The testing service involves handling hazardous materials, which requires proper training and safety precautions to prevent accidents and injuries.

    Test Conditions and Methodology

    The testing service involves the use of plasma spectrochemistry to detect impurities in samples.

    3.1 Testing Equipment and Instruments Used

  • Inductively coupled plasma (ICP) spectrometer
  • Mass spectrometer
  • Sample preparation equipment (e.g., centrifuges, filters)
  • 3.2 Testing Environment Requirements

  • Temperature control: 20-25C
  • Humidity control: 30-60
  • Cleanroom environment
  • 3.3 Sample Preparation Procedures

  • Sample digestion or extraction
  • Filtration and centrifugation
  • Preparation of standards and blanks
  • 3.4 Testing Parameters and Conditions

  • Instrument settings (e.g., wavelength, amplitude)
  • Sample preparation procedures
  • Quality control measures
  • 3.5 Measurement and Analysis Methods

  • Inductively coupled plasma mass spectrometry (ICP-MS)
  • Inductively coupled plasma atomic emission spectroscopy (ICP-AES)
  • 3.6 Calibration and Validation Procedures

  • Instrument calibration: monthly, annually
  • Method validation: quarterly, annually
  • 3.7 Quality Control Measures during Testing

  • Sample handling and labeling
  • Instrument maintenance and calibration
  • Data analysis and interpretation
  • Test Reporting and Documentation

    The test results are documented in a clear and concise manner, including the following information:

  • Sample identification and description
  • Test methods and procedures used
  • Results and data analysis
  • Conclusion and recommendations
  • 4.1 Documenting and Reporting Test Results

  • Report format: USP <730> template or custom report template
  • Data presentation: tables, figures, charts
  • Conclusion and recommendations: clear and concise language
  • 4.2 Report Format and Structure

  • Introduction: overview of test methods and procedures used
  • Results: data analysis and interpretation
  • Discussion: conclusion and recommendations
  • References: relevant standards and publications
  • 4.3 Interpretation of Test Results

  • Comparison with regulatory limits and thresholds
  • Identification of impurities and adulterants
  • Recommendation for further testing or action
  • Why This Test Should Be Performed

    The benefits of USP <730> testing include:

  • Ensuring product safety and efficacy
  • Meeting regulatory requirements
  • Protecting brand reputation
  • Identifying impurities and adulterants
  • 5.1 Benefits and Advantages

  • High-quality products
  • Regulatory compliance
  • Brand protection
  • Product recalls prevented
  • 5.2 Risk Assessment and Mitigation through Testing

  • Identification of potential risks and hazards
  • Mitigation strategies: corrective actions, preventative measures
  • 5.3 Quality Assurance and Compliance Benefits

  • Ensuring product quality and safety
  • Meeting regulatory requirements
  • Protecting brand reputation
  • 5.4 Competitive Advantages and Market Positioning

  • Demonstrating commitment to quality and safety
  • Differentiating products from competitors
  • Enhancing market position
  • Why Eurolab Should Provide This Service

    Eurolab offers a range of benefits and advantages for clients, including:

  • Expertise and experience in this field
  • State-of-the-art equipment and facilities
  • Qualified and certified personnel
  • Accreditation and certification details
  • 6.1 Expertise and Experience in this Field

  • Years of experience in testing and analysis
  • Knowledge of regulatory requirements
  • Understanding of client needs and expectations
  • 6.2 State-of-the-Art Equipment and Facilities

  • Up-to-date equipment and instrumentation
  • Cleanroom environment for sample preparation
  • Secure storage facilities for hazardous materials
  • 6.3 Qualified and Certified Personnel

  • Experienced analysts with advanced degrees
  • Trained in proper handling and disposal of hazardous materials
  • Certified by relevant professional organizations (e.g., ASQ, RSC)
  • 6.4 Accreditation and Certification Details

  • Accredited by relevant accrediting bodies (e.g., NIST, UKAS)
  • Certified to ISO 9001:2015 standard for quality management systems
  • Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers